Latuda (Sunovion Pharmaceuticals Inc.)


Welcome to the PulseAid listing for the Latuda drug offered from Sunovion Pharmaceuticals Inc.. This Atypical Antipsychotic [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Sunovion Pharmaceuticals Inc.
NON-PROPRIETARY NAME: lurasidone hydrochloride
SUBSTANCE NAME: LURASIDONE HYDROCHLORIDE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Atypical Antipsychotic [EPC]
ROUTE: ORAL
DOSAGE FORM: TABLET, FILM COATED
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2011-12-07
END MARKETING DATE: 0000-00-00


Latuda HUMAN PRESCRIPTION DRUG Details:

Item DescriptionLatuda from Sunovion Pharmaceuticals Inc.
LABELER NAME: Sunovion Pharmaceuticals Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 20(mg/1)
START MARKETING DATE: 2011-12-07
END MARKETING DATE: 0000-00-00
PRODUCT ID: 63402-302_1ac4f198-aee2-4db4-917e-8896a31a36ec
PRODUCT NDC: 63402-302
APPLICATION NUMBER: NDA200603

Other LURASIDONE HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Sunovion Pharmaceuticals Inc.Latuda